We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+9.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$24.1B
AUM Growth
-$134M
(-0.56%)
Cap. Flow
-$2.11B
Cap. Flow
% of AUM
-8.76%
Top 10 Holdings %
Top 10 Hldgs %
23.77%
Holding
1,984
New
527
Increased
347
Reduced
445
Closed
587
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$157M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$135M |
| 3 |
Salesforce
CRM
|
+$135M |
| 4 |
IBM
IBM
|
+$130M |
| 5 |
Dell
DELL
|
+$114M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$313M |
| 2 |
Apple
AAPL
|
+$207M |
| 3 |
Intel
INTC
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$159M |
| 5 |
Centene
CNC
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.31% |
| 2 | Technology | 17.95% |
| 3 | Communication Services | 13.61% |
| 4 | Consumer Discretionary | 12.67% |
| 5 | Financials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SIX
1051
DELISTED
Six Flags Entertainment Corp.
SIX
| $859K | ﹤0.01% |
+19,849
| New | +$895K |
|
|
TBIO
1052
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $855K | ﹤0.01% |
+31,061
| New | +$610K |
|
1053
DigitalBridge
DBRG
$2.95B
| $852K | ﹤0.01% |
+26,951
| New | +$770K |
|
|
AMPI
1054
DELISTED
Advanced Merger Partners Inc
AMPI
| $852K | ﹤0.01% |
+87,498
| New | +$858K |
|
1055
Navios Maritime Partners
NMM
$2.26B
| $851K | ﹤0.01% |
+28,804
| New | +$835K |
|
1056
SEI Investments
SEIC
$12.6B
| $851K | ﹤0.01% |
+13,734
| New | +$856K |
|
1057
Telos
TLS
$358M
| $851K | ﹤0.01% |
+25,011
| New | +$842K |
|
|
JOYY
1058
JOYY Inc
JOYY
$3.75B
| $849K | ﹤0.01% |
+12,863
| New | +$1.09M |
|
1059
Brookfield Infrastructure Partners
BIP
$18B
| $843K | ﹤0.01% |
+22,746
| New | +$822K |
|
1060
Agilent Technologies
A
$41.2B
| $842K | ﹤0.01% |
5,698
-574,766
| -99% | -$78.4M |
|
1061
SFL Corp
SFL
$1.61B
| $842K | ﹤0.01% |
+109,981
| New | +$901K |
|
1062
Stantec
STN
$8.39B
| $841K | ﹤0.01% |
+18,836
| New | +$849K |
|
|
CMMB
1063
Chemomab Therapeutics
CMMB
$14.1M
| $837K | ﹤0.01% |
+11,009
| New | +$1.08M |
|
1064
CALL
Envoy Medical Warrant
COCHW
$574K
| $833K | ﹤0.01% |
+83,333
| New | +$59.4K |
|
1065
Pangaea Logistics
PANL
$485M
| $827K | ﹤0.01% |
+164,968
| New | +$639K |
|
1066
Crinetics Pharmaceuticals
CRNX
$8.92B
| $824K | ﹤0.01% |
+43,671
| New | +$767K |
|
1067
Alibaba
BABA
$308B
| $823K | ﹤0.01% |
3,630
+1,890
| +109% | +$420K |
|
|
ATC
1068
DELISTED
Atotech Limited
ATC
| $816K | ﹤0.01% |
31,970
-439,683
| -93% | -$10.2M |
|
1069
Sutro Biopharma
STRO
$421M
| $814K | ﹤0.01% |
4,376
-13,358
| -75% | -$2.61M |
|
1070
J. Jill
JILL
$283M
| $812K | ﹤0.01% |
+41,260
| New | +$571K |
|
|
CCMP
1071
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $808K | ﹤0.01% |
+5,368
| New | +$889K |
|
1072
Eastman Chemical
EMN
$8.42B
| $804K | ﹤0.01% |
+6,886
| New | +$827K |
|
1073
JD.com
JD
$44.5B
| $799K | ﹤0.01% |
10,017
-55,427
| -85% | -$4.17M |
|
1074
Coinbase
COIN
$40.5B
| $790K | ﹤0.01% |
+3,118
| New | +$809K |
|
1075
EQT Corp
EQT
$32.3B
| $790K | ﹤0.01% |
+35,500
| New | +$717K |
|
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace North America held 1,984 positions worth $24.1B, down 0.56% from $24.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Marshall Wace North America withdrew a net $2.11B in Q2 2021, closing 587 positions and reducing 445 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $119M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Marshall Wace North America opened a new position in Syneos Health, Inc. Class A Common Stock worth $83.7M.
- Marshall Wace North America's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 935,304 shares worth $83.7M.
- Marshall Wace North America added most to Johnson & Johnson in Q2 2021, an estimated $157M increase.
- Marshall Wace North America's biggest Q2 2021 reduction was Microsoft, cutting an estimated $313M.
- Marshall Wace North America fully exited State Street SPDR S&P 500 ETF Trust in Q2 2021, selling an estimated $119M.
- Marshall Wace North America's ten largest holdings make up 24% of its $24.1B portfolio in Q2 2021.
- Marshall Wace North America opened 527 new positions and closed 587 in Q2 2021.
- Marshall Wace North America's portfolio value fell 0.56% quarter-over-quarter to $24.1B.
Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.